- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02008630
Animal-assisted Interventions in Health Promotion for Elderly With Dementia
Animal-assisted Interventions in Health Promotion for Elderly With Dementia; Impact on Factors Related to Risk of Falls
The overall research aim of this study is to investigate changes in measures related to the risk of falls among elderly with dementia participating in animal-assisted interventions. Also relatives' experience of own and the elderly's situation during and after the intervention will be examined. The design will be a prospective and cluster randomized multicenter trial, but mixed-methods will be used to target different outcomes. The study population will be elderly (age above 65) at day care centers diagnosed with dementia, or having a cognitive deficit. The intervention will consist of 30 minutes sessions with animal-assisted activity or animal-assisted therapy two times a week for 12 weeks in groups of 4-6 participants. Control groups will receive treatment as usual. Research questions:
- Is there an effect in use of ordinary and optional medication among elderly persons with dementia at day care centers participating in animal-assisted interventions compared to a control group?
- Is there an effect on social interaction, quality of life, activeness and wellbeing among elderly persons with dementia at day care centers participating in animal-assisted interventions compared to a control group?
- Is there an effect on balance among elderly persons with dementia at day care centers participating in animal-assisted therapy compared to animal-assisted activity or a control group?
- Do relatives of elderly persons with dementia at day care centers experience a change in their own and the elderly's situation after the intervention compared with before the intervention started?
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Asker, Norway
- Solgården Dagsenter
-
Bærum, Norway
- Lommedalen dagsenter
-
Bærum, Norway
- Vallerhjemmet dagsenter
-
Fet, Norway
- Pålsetunet dagsenter
-
Fjerdingby, Norway
- Fjerdingby dagsenter
-
Fredrikstad, Norway
- Glemmen dagsenter
-
Larvik, Norway
- Tjølling dagsenter
-
Lillestrøm, Norway
- Husebyjordet dagsenter
-
Lillestrøm, Norway
- Åråsveien dagsenter
-
Moss, Norway
- Myraveien Dagsenter
-
Moss, Norway
- Skogbrynet dagsenter
-
Nedre Eiker, Norway
- Dagsenter Nedre Eiker
-
Nes, Norway
- Nes dagsenter
-
Nøtterøy, Norway
- Bjønnesåsen Dagsenter
-
Oppegård, Norway
- Bjørkås dagsenter
-
Re, Norway
- Re Dagsenter
-
Sande, Norway
- Sandetun dagsenter
-
Sandefjord, Norway
- Lunden dagsenter
-
Sørum, Norway
- Sørvald dagsenter
-
Tønsberg, Norway
- Eik dagsenter
-
Tønsberg, Norway
- Nes dagsenter
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of dementia or having a cognitive deficit measured as a score less than 25 on Mini-Mental State Examination.
Exclusion Criteria:
- Fear of dogs, dog allergy or need of wheel chair
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Animal-assisted activity
30 minutes group session with animal-assisted activity twice a week for 12 weeks in groups of 4-6 participants.
|
|
Experimental: Animal-assisted therapy
30 minutes group session with animal-assisted therapy twice a week for 12 weeks in groups of 4-6 participants
|
|
No Intervention: Control
Control group with treatment as usual
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Norwegian version of Berg balance test
Time Frame: Second last or last week before the intervention starts, after 4 and 8 weeks of the intervention, and first or second week after end of intervention. A follow-up measure 3 months after end of the intervention
|
Second last or last week before the intervention starts, after 4 and 8 weeks of the intervention, and first or second week after end of intervention. A follow-up measure 3 months after end of the intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Norwegian version of Quality of Life in Late-Stage Dementia (QUALID)
Time Frame: Second last or last week before the intervention starts, after 6 weeks of the intervention, and first or second week after end of intervention. A follow-up measure 3 months after end of the intervention
|
Second last or last week before the intervention starts, after 6 weeks of the intervention, and first or second week after end of intervention. A follow-up measure 3 months after end of the intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in physical activity measured by Actigraphy
Time Frame: Second last or last week before the intervention starts, after 6 weeks of the intervention, and first or second week after end of intervention
|
A device worn by the participants for one week at each time point of measure, night and day, measuring physical movement.
Will be used to calculate physical activity during day time and sleep efficacy during the night.
|
Second last or last week before the intervention starts, after 6 weeks of the intervention, and first or second week after end of intervention
|
Video recordings of two group session at each location
Time Frame: After two and ten weeks of the intervention
|
The video recordings will be analyzed with respect to social interaction and group dynamics
|
After two and ten weeks of the intervention
|
Change in optional and ordinary medication
Time Frame: Second last or last week before the intervention starts, first or second week after the end of intervention. A follow-up measure 3 months after end of the intervention
|
Second last or last week before the intervention starts, first or second week after the end of intervention. A follow-up measure 3 months after end of the intervention
|
Collaborators and Investigators
Investigators
- Principal Investigator: Camilla Ihlebæk, PhD, Norwegian University of Life Sciences
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012/1144-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityRecruitingDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeRecruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Cognito Therapeutics, Inc.Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia ModerateUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
-
University College, LondonNot yet recruitingDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal | DEM
-
University College, LondonThe University of Hong KongUnknownDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal
-
Karolinska InstitutetRegion Stockholm; KTH Royal Institute of TechnologyActive, not recruitingAlzheimer Dementia | Dementia DisordersSweden
Clinical Trials on Animal-assisted activity
-
Atlas UniversityNot yet recruitingDepression | Loneliness | Old Age; Debility | Nursing Home | Loss of Interest in Activities
-
Norwegian University of Life SciencesVestfold University CollegeCompleted
-
Swiss Tropical & Public Health InstituteRehab Basel; University of BaselCompletedBrain Injuries | Consciousness DisorderSwitzerland
-
Washington State UniversityCompletedStress, Psychological | Stress, Physiological
-
University of Colorado, DenverPurdue University; Human Animal Bond Institute for ResearchCompletedAutism Spectrum Disorder | Child Behavior | Psychiatric Hospitalization | Veterinary Therapeutics
-
Şeyma DemiralayCompletedStress | Child | Social Anxiety | Nursing Caries | Disabling Disease | Animal CommunicationTurkey
-
Universitair Ziekenhuis BrusselCompletedHospitalization in ChildrenBelgium
-
Daniel Collado-MateoAsociación Dame La PataRecruitingWork Related Stress | Occupational GroupsSpain
-
Daniel Collado-MateoPurina España (Reg. Trademark of Nestle S.A.)Enrolling by invitationEating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/BulimiaSpain
-
Daniel Collado-MateoAsociación de Padres de Personas Con Autismo (APNA); Asociación Nuevo Horizonte and other collaboratorsEnrolling by invitationAutism Spectrum Disorder | AutismSpain